Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

JAK inhibitors show promise for treating various skin diseases.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Biologics for severe asthma have known side effects, but some new risks need more study.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Some systemic treatments work for nail psoriasis but can have serious side effects.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Stem-cell therapy shows promise for skin conditions but needs more research.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

TNF-alpha inhibitors can cause various immune-related skin issues.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Physical activity, height, and smoking affect prostate cancer risk.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.